Denmark· DK-28105111312
Tybost
A cobicistat product containing cobicistat, registered in Denmark by Gilead Sciences Ireland UC. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Cobicistat is registered in 9 of 19 countries.
Countries holding a registration under ATC V03AX03 (cobicistat), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 5 of them publish a price we can compare per daily dose
Cobicistat · ATC V03AX03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Cobicistat
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Denmark (DK)
- ATC code
- V03AX03
- ATC class
- Cobicistat
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105111312
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
541 interactions on record for cobicistat.
Graded by severity as the source publishes them — 243 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cobicistat · interactions on record
541 records
- 243 severe
- 277 moderate
- 21 minor
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- EluxadolineA07DA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V03AX03
Cobicistat, as other registers publish it.
- FinlandTybostGilead Sciences Ireland UC
- PolandTybostGilead Sciences Ireland UC
- United StatesTybostGilead Sciences, Inc.
- CzechiaTYBOSTGilead Sciences Ireland UC, Carrigtohill
- CzechiaTYBOSTGilead Sciences Ireland UC, Carrigtohill
- BelgiumTybost 150 mgGilead Sciences Ireland UC
- IrelandTybost 150 mg film-coated tabletsGilead Sciences Ireland UC
- NetherlandsTybost 150 mg filmomhulde tablettenGilead Sciences Ireland UC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b62d923f-0c9e-437f-881a-25ac115638c0 GET /v1/drugs/b62d923f-0c9e-437f-881a-25ac115638c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "150 mg",
"auth_role": "MOD",
"dk_drugid": "28105111312",
"substance": "Cobicistat",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "41536"
}See everything about cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.